カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ムコ多糖症Ⅱ型の世界市場見通し2023年-2029年

◆英語タイトル：Mucopolysaccharidosis II Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5781）◆商品コード：MMG23JU5781
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥474,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥616,850見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥711,750見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Mucopolysaccharidosis II Market 調査レポートは次の情報を含め、グローバルにおけるのムコ多糖症Ⅱ型市場規模と予測を収録しています。・世界のムコ多糖症Ⅱ型市場：売上、2018年-2023年、2024年-2029年
・世界のムコ多糖症Ⅱ型市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のムコ多糖症Ⅱ型市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「JR-141」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ムコ多糖症Ⅱ型のグローバル主要企業は、Alexion Pharmaceuticals, Inc.、 AngioChem Inc.、 ArmaGen Inc.、 Bioasis Technologies Inc.、 Green Cross Corporation、 Inventiva、 JCR Pharmaceuticals Co., Ltd.、 Laboratorios Del Dr. Esteve S.A.、 RegenxBio Inc.、 Sangamo BioSciences, Inc.、 Takedaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ムコ多糖症Ⅱ型のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のムコ多糖症Ⅱ型市場：タイプ別、2018年-2023年、2024年-2029年
世界のムコ多糖症Ⅱ型市場：タイプ別市場シェア、2022年
・JR-141、EGT-301、DUOC-01、AGT-182、JR-032、その他

世界のムコ多糖症Ⅱ型市場：用途別、2018年-2023年、2024年-2029年
世界のムコ多糖症Ⅱ型市場：用途別市場シェア、2022年
・病院、診療所、研究センター、その他

世界のムコ多糖症Ⅱ型市場：地域・国別、2018年-2023年、2024年-2029年
世界のムコ多糖症Ⅱ型市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるムコ多糖症Ⅱ型のグローバル売上、2018年-2023年
・主要企業におけるムコ多糖症Ⅱ型のグローバル売上シェア、2022年
・主要企業におけるムコ多糖症Ⅱ型のグローバル販売量、2018年-2023年
・主要企業におけるムコ多糖症Ⅱ型のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Alexion Pharmaceuticals, Inc.、 AngioChem Inc.、 ArmaGen Inc.、 Bioasis Technologies Inc.、 Green Cross Corporation、 Inventiva、 JCR Pharmaceuticals Co., Ltd.、 Laboratorios Del Dr. Esteve S.A.、 RegenxBio Inc.、 Sangamo BioSciences, Inc.、 Takeda

*************************************************************

・調査・分析レポートの概要
ムコ多糖症Ⅱ型市場の定義
市場セグメント
世界のムコ多糖症Ⅱ型市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のムコ多糖症Ⅱ型市場規模
世界のムコ多糖症Ⅱ型市場規模：2022年 VS 2029年
世界のムコ多糖症Ⅱ型市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのムコ多糖症Ⅱ型の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のムコ多糖症Ⅱ型製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：JR-141、EGT-301、DUOC-01、AGT-182、JR-032、その他
ムコ多糖症Ⅱ型のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、研究センター、その他
ムコ多糖症Ⅱ型の用途別グローバル売上・予測

・地域別市場分析
地域別ムコ多糖症Ⅱ型市場規模 2022年と2029年
地域別ムコ多糖症Ⅱ型売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Alexion Pharmaceuticals, Inc.、 AngioChem Inc.、 ArmaGen Inc.、 Bioasis Technologies Inc.、 Green Cross Corporation、 Inventiva、 JCR Pharmaceuticals Co., Ltd.、 Laboratorios Del Dr. Esteve S.A.、 RegenxBio Inc.、 Sangamo BioSciences, Inc.、 Takeda
...

This report aims to provide a comprehensive presentation of the global market for Mucopolysaccharidosis II, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mucopolysaccharidosis II. This report contains market size and forecasts of Mucopolysaccharidosis II in global, including the following market information:
Global Mucopolysaccharidosis II Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Mucopolysaccharidosis II Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Mucopolysaccharidosis II companies in 2022 (%)
The global Mucopolysaccharidosis II market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
JR-141 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Mucopolysaccharidosis II include Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, Inventiva, JCR Pharmaceuticals Co., Ltd., Laboratorios Del Dr. Esteve S.A. and RegenxBio Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mucopolysaccharidosis II manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mucopolysaccharidosis II Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Mucopolysaccharidosis II Market Segment Percentages, by Type, 2022 (%)
JR-141
EGT-301
DUOC-01
AGT-182
JR-032
Others
Global Mucopolysaccharidosis II Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Mucopolysaccharidosis II Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Research Center
Others
Global Mucopolysaccharidosis II Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Mucopolysaccharidosis II Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mucopolysaccharidosis II revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Mucopolysaccharidosis II revenues share in global market, 2022 (%)
Key companies Mucopolysaccharidosis II sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Mucopolysaccharidosis II sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alexion Pharmaceuticals, Inc.
AngioChem Inc.
ArmaGen Inc.
Bioasis Technologies Inc.
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co., Ltd.
Laboratorios Del Dr. Esteve S.A.
RegenxBio Inc.
Sangamo BioSciences, Inc.
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mucopolysaccharidosis II, market overview.
Chapter 2: Global Mucopolysaccharidosis II market size in revenue and volume.
Chapter 3: Detailed analysis of Mucopolysaccharidosis II manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mucopolysaccharidosis II in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Mucopolysaccharidosis II capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Mucopolysaccharidosis II Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mucopolysaccharidosis II Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mucopolysaccharidosis II Overall Market Size
2.1 Global Mucopolysaccharidosis II Market Size: 2022 VS 2029
2.2 Global Mucopolysaccharidosis II Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Mucopolysaccharidosis II Sales: 2018-2029
3 Company Landscape
3.1 Top Mucopolysaccharidosis II Players in Global Market
3.2 Top Global Mucopolysaccharidosis II Companies Ranked by Revenue
3.3 Global Mucopolysaccharidosis II Revenue by Companies
3.4 Global Mucopolysaccharidosis II Sales by Companies
3.5 Global Mucopolysaccharidosis II Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Mucopolysaccharidosis II Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Mucopolysaccharidosis II Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mucopolysaccharidosis II Players in Global Market
3.8.1 List of Global Tier 1 Mucopolysaccharidosis II Companies
3.8.2 List of Global Tier 2 and Tier 3 Mucopolysaccharidosis II Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Mucopolysaccharidosis II Market Size Markets, 2022 & 2029
4.1.2 JR-141
4.1.3 EGT-301
4.1.4 DUOC-01
4.1.5 AGT-182
4.1.6 JR-032
4.1.7 Others
4.2 By Type – Global Mucopolysaccharidosis II Revenue & Forecasts
4.2.1 By Type – Global Mucopolysaccharidosis II Revenue, 2018-2023
4.2.2 By Type – Global Mucopolysaccharidosis II Revenue, 2024-2029
4.2.3 By Type – Global Mucopolysaccharidosis II Revenue Market Share, 2018-2029
4.3 By Type – Global Mucopolysaccharidosis II Sales & Forecasts
4.3.1 By Type – Global Mucopolysaccharidosis II Sales, 2018-2023
4.3.2 By Type – Global Mucopolysaccharidosis II Sales, 2024-2029
4.3.3 By Type – Global Mucopolysaccharidosis II Sales Market Share, 2018-2029
4.4 By Type – Global Mucopolysaccharidosis II Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Mucopolysaccharidosis II Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Center
5.1.5 Others
5.2 By Application – Global Mucopolysaccharidosis II Revenue & Forecasts
5.2.1 By Application – Global Mucopolysaccharidosis II Revenue, 2018-2023
5.2.2 By Application – Global Mucopolysaccharidosis II Revenue, 2024-2029
5.2.3 By Application – Global Mucopolysaccharidosis II Revenue Market Share, 2018-2029
5.3 By Application – Global Mucopolysaccharidosis II Sales & Forecasts
5.3.1 By Application – Global Mucopolysaccharidosis II Sales, 2018-2023
5.3.2 By Application – Global Mucopolysaccharidosis II Sales, 2024-2029
5.3.3 By Application – Global Mucopolysaccharidosis II Sales Market Share, 2018-2029
5.4 By Application – Global Mucopolysaccharidosis II Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Mucopolysaccharidosis II Market Size, 2022 & 2029
6.2 By Region – Global Mucopolysaccharidosis II Revenue & Forecasts
6.2.1 By Region – Global Mucopolysaccharidosis II Revenue, 2018-2023
6.2.2 By Region – Global Mucopolysaccharidosis II Revenue, 2024-2029
6.2.3 By Region – Global Mucopolysaccharidosis II Revenue Market Share, 2018-2029
6.3 By Region – Global Mucopolysaccharidosis II Sales & Forecasts
6.3.1 By Region – Global Mucopolysaccharidosis II Sales, 2018-2023
6.3.2 By Region – Global Mucopolysaccharidosis II Sales, 2024-2029
6.3.3 By Region – Global Mucopolysaccharidosis II Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Mucopolysaccharidosis II Revenue, 2018-2029
6.4.2 By Country – North America Mucopolysaccharidosis II Sales, 2018-2029
6.4.3 US Mucopolysaccharidosis II Market Size, 2018-2029
6.4.4 Canada Mucopolysaccharidosis II Market Size, 2018-2029
6.4.5 Mexico Mucopolysaccharidosis II Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Mucopolysaccharidosis II Revenue, 2018-2029
6.5.2 By Country – Europe Mucopolysaccharidosis II Sales, 2018-2029
6.5.3 Germany Mucopolysaccharidosis II Market Size, 2018-2029
6.5.4 France Mucopolysaccharidosis II Market Size, 2018-2029
6.5.5 U.K. Mucopolysaccharidosis II Market Size, 2018-2029
6.5.6 Italy Mucopolysaccharidosis II Market Size, 2018-2029
6.5.7 Russia Mucopolysaccharidosis II Market Size, 2018-2029
6.5.8 Nordic Countries Mucopolysaccharidosis II Market Size, 2018-2029
6.5.9 Benelux Mucopolysaccharidosis II Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Mucopolysaccharidosis II Revenue, 2018-2029
6.6.2 By Region – Asia Mucopolysaccharidosis II Sales, 2018-2029
6.6.3 China Mucopolysaccharidosis II Market Size, 2018-2029
6.6.4 Japan Mucopolysaccharidosis II Market Size, 2018-2029
6.6.5 South Korea Mucopolysaccharidosis II Market Size, 2018-2029
6.6.6 Southeast Asia Mucopolysaccharidosis II Market Size, 2018-2029
6.6.7 India Mucopolysaccharidosis II Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Mucopolysaccharidosis II Revenue, 2018-2029
6.7.2 By Country – South America Mucopolysaccharidosis II Sales, 2018-2029
6.7.3 Brazil Mucopolysaccharidosis II Market Size, 2018-2029
6.7.4 Argentina Mucopolysaccharidosis II Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Mucopolysaccharidosis II Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Mucopolysaccharidosis II Sales, 2018-2029
6.8.3 Turkey Mucopolysaccharidosis II Market Size, 2018-2029
6.8.4 Israel Mucopolysaccharidosis II Market Size, 2018-2029
6.8.5 Saudi Arabia Mucopolysaccharidosis II Market Size, 2018-2029
6.8.6 UAE Mucopolysaccharidosis II Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Alexion Pharmaceuticals, Inc.
7.1.1 Alexion Pharmaceuticals, Inc. Company Summary
7.1.2 Alexion Pharmaceuticals, Inc. Business Overview
7.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Major Product Offerings
7.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.1.5 Alexion Pharmaceuticals, Inc. Key News & Latest Developments
7.2 AngioChem Inc.
7.2.1 AngioChem Inc. Company Summary
7.2.2 AngioChem Inc. Business Overview
7.2.3 AngioChem Inc. Mucopolysaccharidosis II Major Product Offerings
7.2.4 AngioChem Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.2.5 AngioChem Inc. Key News & Latest Developments
7.3 ArmaGen Inc.
7.3.1 ArmaGen Inc. Company Summary
7.3.2 ArmaGen Inc. Business Overview
7.3.3 ArmaGen Inc. Mucopolysaccharidosis II Major Product Offerings
7.3.4 ArmaGen Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.3.5 ArmaGen Inc. Key News & Latest Developments
7.4 Bioasis Technologies Inc.
7.4.1 Bioasis Technologies Inc. Company Summary
7.4.2 Bioasis Technologies Inc. Business Overview
7.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Major Product Offerings
7.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.4.5 Bioasis Technologies Inc. Key News & Latest Developments
7.5 Green Cross Corporation
7.5.1 Green Cross Corporation Company Summary
7.5.2 Green Cross Corporation Business Overview
7.5.3 Green Cross Corporation Mucopolysaccharidosis II Major Product Offerings
7.5.4 Green Cross Corporation Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.5.5 Green Cross Corporation Key News & Latest Developments
7.6 Inventiva
7.6.1 Inventiva Company Summary
7.6.2 Inventiva Business Overview
7.6.3 Inventiva Mucopolysaccharidosis II Major Product Offerings
7.6.4 Inventiva Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.6.5 Inventiva Key News & Latest Developments
7.7 JCR Pharmaceuticals Co., Ltd.
7.7.1 JCR Pharmaceuticals Co., Ltd. Company Summary
7.7.2 JCR Pharmaceuticals Co., Ltd. Business Overview
7.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Major Product Offerings
7.7.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.7.5 JCR Pharmaceuticals Co., Ltd. Key News & Latest Developments
7.8 Laboratorios Del Dr. Esteve S.A.
7.8.1 Laboratorios Del Dr. Esteve S.A. Company Summary
7.8.2 Laboratorios Del Dr. Esteve S.A. Business Overview
7.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Major Product Offerings
7.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.8.5 Laboratorios Del Dr. Esteve S.A. Key News & Latest Developments
7.9 RegenxBio Inc.
7.9.1 RegenxBio Inc. Company Summary
7.9.2 RegenxBio Inc. Business Overview
7.9.3 RegenxBio Inc. Mucopolysaccharidosis II Major Product Offerings
7.9.4 RegenxBio Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.9.5 RegenxBio Inc. Key News & Latest Developments
7.10 Sangamo BioSciences, Inc.
7.10.1 Sangamo BioSciences, Inc. Company Summary
7.10.2 Sangamo BioSciences, Inc. Business Overview
7.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Major Product Offerings
7.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.10.5 Sangamo BioSciences, Inc. Key News & Latest Developments
7.11 Takeda
7.11.1 Takeda Company Summary
7.11.2 Takeda Mucopolysaccharidosis II Business Overview
7.11.3 Takeda Mucopolysaccharidosis II Major Product Offerings
7.11.4 Takeda Mucopolysaccharidosis II Sales and Revenue in Global (2018-2023)
7.11.5 Takeda Key News & Latest Developments
8 Global Mucopolysaccharidosis II Production Capacity, Analysis
8.1 Global Mucopolysaccharidosis II Production Capacity, 2018-2029
8.2 Mucopolysaccharidosis II Production Capacity of Key Manufacturers in Global Market
8.3 Global Mucopolysaccharidosis II Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Mucopolysaccharidosis II Supply Chain Analysis
10.1 Mucopolysaccharidosis II Industry Value Chain
10.2 Mucopolysaccharidosis II Upstream Market
10.3 Mucopolysaccharidosis II Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mucopolysaccharidosis II Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Mucopolysaccharidosis II in Global Market
Table 2. Top Mucopolysaccharidosis II Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Mucopolysaccharidosis II Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Mucopolysaccharidosis II Revenue Share by Companies, 2018-2023
Table 5. Global Mucopolysaccharidosis II Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Mucopolysaccharidosis II Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Mucopolysaccharidosis II Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Mucopolysaccharidosis II Product Type
Table 9. List of Global Tier 1 Mucopolysaccharidosis II Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mucopolysaccharidosis II Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Mucopolysaccharidosis II Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Mucopolysaccharidosis II Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Mucopolysaccharidosis II Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Mucopolysaccharidosis II Sales (K Pcs), 2018-2023
Table 15. By Type - Global Mucopolysaccharidosis II Sales (K Pcs), 2024-2029
Table 16. By Application – Global Mucopolysaccharidosis II Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Mucopolysaccharidosis II Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Mucopolysaccharidosis II Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Mucopolysaccharidosis II Sales (K Pcs), 2018-2023
Table 20. By Application - Global Mucopolysaccharidosis II Sales (K Pcs), 2024-2029
Table 21. By Region – Global Mucopolysaccharidosis II Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Mucopolysaccharidosis II Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Mucopolysaccharidosis II Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Mucopolysaccharidosis II Sales (K Pcs), 2018-2023
Table 25. By Region - Global Mucopolysaccharidosis II Sales (K Pcs), 2024-2029
Table 26. By Country - North America Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Mucopolysaccharidosis II Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Mucopolysaccharidosis II Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Mucopolysaccharidosis II Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Mucopolysaccharidosis II Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Mucopolysaccharidosis II Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Mucopolysaccharidosis II Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Mucopolysaccharidosis II Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Mucopolysaccharidosis II Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Mucopolysaccharidosis II Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Mucopolysaccharidosis II Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Mucopolysaccharidosis II Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Mucopolysaccharidosis II Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Mucopolysaccharidosis II Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Mucopolysaccharidosis II Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Mucopolysaccharidosis II Sales, (K Pcs), 2024-2029
Table 46. Alexion Pharmaceuticals, Inc. Company Summary
Table 47. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Offerings
Table 48. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Alexion Pharmaceuticals, Inc. Key News & Latest Developments
Table 50. AngioChem Inc. Company Summary
Table 51. AngioChem Inc. Mucopolysaccharidosis II Product Offerings
Table 52. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. AngioChem Inc. Key News & Latest Developments
Table 54. ArmaGen Inc. Company Summary
Table 55. ArmaGen Inc. Mucopolysaccharidosis II Product Offerings
Table 56. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. ArmaGen Inc. Key News & Latest Developments
Table 58. Bioasis Technologies Inc. Company Summary
Table 59. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Offerings
Table 60. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Bioasis Technologies Inc. Key News & Latest Developments
Table 62. Green Cross Corporation Company Summary
Table 63. Green Cross Corporation Mucopolysaccharidosis II Product Offerings
Table 64. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Green Cross Corporation Key News & Latest Developments
Table 66. Inventiva Company Summary
Table 67. Inventiva Mucopolysaccharidosis II Product Offerings
Table 68. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Inventiva Key News & Latest Developments
Table 70. JCR Pharmaceuticals Co., Ltd. Company Summary
Table 71. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Offerings
Table 72. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. JCR Pharmaceuticals Co., Ltd. Key News & Latest Developments
Table 74. Laboratorios Del Dr. Esteve S.A. Company Summary
Table 75. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Offerings
Table 76. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Laboratorios Del Dr. Esteve S.A. Key News & Latest Developments
Table 78. RegenxBio Inc. Company Summary
Table 79. RegenxBio Inc. Mucopolysaccharidosis II Product Offerings
Table 80. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. RegenxBio Inc. Key News & Latest Developments
Table 82. Sangamo BioSciences, Inc. Company Summary
Table 83. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Offerings
Table 84. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Sangamo BioSciences, Inc. Key News & Latest Developments
Table 86. Takeda Company Summary
Table 87. Takeda Mucopolysaccharidosis II Product Offerings
Table 88. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Takeda Key News & Latest Developments
Table 90. Mucopolysaccharidosis II Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 91. Global Mucopolysaccharidosis II Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Mucopolysaccharidosis II Production by Region, 2018-2023 (K Pcs)
Table 93. Global Mucopolysaccharidosis II Production by Region, 2024-2029 (K Pcs)
Table 94. Mucopolysaccharidosis II Market Opportunities & Trends in Global Market
Table 95. Mucopolysaccharidosis II Market Drivers in Global Market
Table 96. Mucopolysaccharidosis II Market Restraints in Global Market
Table 97. Mucopolysaccharidosis II Raw Materials
Table 98. Mucopolysaccharidosis II Raw Materials Suppliers in Global Market
Table 99. Typical Mucopolysaccharidosis II Downstream
Table 100. Mucopolysaccharidosis II Downstream Clients in Global Market
Table 101. Mucopolysaccharidosis II Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Mucopolysaccharidosis II Segment by Type in 2022
Figure 2. Mucopolysaccharidosis II Segment by Application in 2022
Figure 3. Global Mucopolysaccharidosis II Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Mucopolysaccharidosis II Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Mucopolysaccharidosis II Revenue, 2018-2029 (US$, Mn)
Figure 7. Mucopolysaccharidosis II Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Mucopolysaccharidosis II Revenue in 2022
Figure 9. By Type - Global Mucopolysaccharidosis II Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 11. By Type - Global Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 12. By Type - Global Mucopolysaccharidosis II Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Mucopolysaccharidosis II Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 15. By Application - Global Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 16. By Application - Global Mucopolysaccharidosis II Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Mucopolysaccharidosis II Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Mucopolysaccharidosis II Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 20. By Region - Global Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 21. By Country - North America Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 22. By Country - North America Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 23. US Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 28. Germany Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 29. France Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 37. China Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 41. India Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 43. By Country - South America Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 44. Brazil Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Mucopolysaccharidosis II Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Mucopolysaccharidosis II Sales Market Share, 2018-2029
Figure 48. Turkey Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Mucopolysaccharidosis II Revenue, (US$, Mn), 2018-2029
Figure 52. Global Mucopolysaccharidosis II Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Mucopolysaccharidosis II by Region, 2022 VS 2029
Figure 54. Mucopolysaccharidosis II Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ムコ多糖症Ⅱ型の世界市場見通し2023年-2029年(Mucopolysaccharidosis II Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 医薬品及び賦形剤の世界市場見通し2023年-2029年
  • エナント酸メテノロンの世界市場見通し2023年-2029年
  • 痔疾患用鎮痛剤の世界市場見通し2023年-2029年
  • 抗凝固薬回復薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆